Quick Answer
STANDARD BIOTOOLS INC. reported Total Assets of $567.75 million for the year ending 2025.
- STANDARD BIOTOOLS INC. showed a decrease of -7.3% in Total Assets from 2024 to 2025.
- This data is from STANDARD BIOTOOLS INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $85.66 million | Q3 2011: $82.60 million | Q1 2012: $70.67 million | Q2 2012: $64.93 million | Q3 2012: $117.10 million | Q1 2013: $113.24 million | Q2 2013: $111.97 million | Q3 2013: $114.24 million | Q1 2014: $424.72 million | Q2 2014: $417.75 million | Q3 2014: $410.39 million | Q1 2015: $395.03 million | Q2 2015: $389.13 million | Q3 2015: $378.49 million | Q1 2016: $354.44 million | Q2 2016: $342.03 million | Q3 2016: $320.42 million | Q1 2017: $292.47 million | Q2 2017: $278.71 million | Q3 2017: $292.00 million | Q1 2018: $269.70 million | Q2 2018: $259.10 million | Q3 2018: $252.29 million | Q1 2019: $291.45 million | Q2 2019: $283.79 million | Q3 2019: $269.39 million | Q1 2020: $290.22 million | Q2 2020: $282.35 million | Q3 2020: $322.98 million | Q1 2021: $305.20 million | Q2 2021: $289.32 million | Q3 2021: $282.19 million | Q1 2022: $271.94 million | Q2 2022: $441.12 million | Q3 2022: $414.92 million | Q1 2023: $371.65 million | Q2 2023: $355.83 million | Q3 2023: $339.29 million | Q1 2024: $777.67 million | Q2 2024: $708.73 million | Q3 2024: $681.54 million | Q1 2025: $579.60 million | Q2 2025: $556.97 million | Q3 2025: $539.64 million.
- Over the full 16 years of available data (2010 to 2025), STANDARD BIOTOOLS INC.'s Total Assets has grown by 2,189.2%.
- Historical annual values: Fiscal year 2025: $567.75 million | Fiscal year 2024: $612.35 million | Fiscal year 2023: $323.07 million | Fiscal year 2022: $390.31 million | Fiscal year 2021: $275.21 million | Fiscal year 2020: $324.76 million | Fiscal year 2019: $264.81 million | Fiscal year 2018: $303.65 million | Fiscal year 2017: $287.35 million | Fiscal year 2016: $306.40 million | Fiscal year 2015: $370.05 million | Fiscal year 2014: $407.56 million | Fiscal year 2013: $116.92 million | Fiscal year 2012: $113.73 million | Fiscal year 2011: $79.33 million | Fiscal year 2010: $24.80 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: